The Biden administration has announced a plan to share 75% of its donated COVID-19 vaccine doses through COVAX. Some 20 million Pfizer, Moderna and Johnson & Johnson vaccine doses will be sent to low- and middle-income countries through the program. (CNBC Weekly)

Verily has hired oncologist and former FDA official Amy Abernethy as president of its clinical research business, a role in which she’ll help lead the company’s Project Baseline platform. Abernethy previously served as principal deputy commissioner at the FDA, where she supervised the agency’s upgraded data practices. (STAT)

To boost the manufacturing of mRNA vaccines, Samsung will expand its drug substance production at a South Korea plant. The company noted that, due to its safety and scalability, “mRNA has been the technology of choice for many COVID-19 vaccines.” (Endpoints News)

Bristol Myers Squibb is being sued for delaying the approval of its cancer drug, Breyanzi, to avoid payouts to Celgene shareholders. The complaint alleges the company delayed the Food and Drug Administration approval deadline in order to acquire Celgene at an “enormous discount.” (Reuters)

Canada, EU nations and other wealthy countries have signed deals to reserve hundreds of millions of COVID-19 vaccine doses through 2023. The deals further expand the gap in vaccine access between wealthier and low-income countries. (The Wall Street Journal)